Keep in mind that GLP-1 RAs affect the brain, reducing cravings
5 A critical observation is that the increase in GLP1 drug use within Medicare Part D has outpaced the growth in the diabetic patient population
GLP-1 RAs also reduce blood pressure, improve renal function, reduce chronic inflammation, reduce lipoprotein, reduce chylomicron, increase postprandial triglycerides, increase very-low-density lipoprotein cholesterol (VLDL-C), and increase free fatty acids (20)
Gastrointestinal side effects : The most common adverse effects of semaglutide involve the gastrointestinal tract
Choosing the right peptide depends on your goals
Expect oral GHK-Cu effect size to sit between topical and injectable